Table 6.
Ref. | Design | Cases | Technical success | Clinical success | Complications1 |
Baron et al[121] | CR | 1 | 100% | 100% | None |
Kwan et al[122] | RS | 3 | 100% | 100% | 33% |
Lee et al[123] | PS | 9 | 100% | 100% | 11% |
Takasawa et al[124] | CR | 1 | 100% | 100% | None |
Kamata et al[125] | CR | 1 | 100% | 100% | None |
Kamata et al[126] | CR | 1 | 100% | 100% | None |
Song et al[127] | PS | 8 | 100% | 100% | 37% |
Súbtil et al[128] | RS | 4 | 100% | 100% | 25% |
Itoi et al[129] | CR | 2 | 100% | 100% | None |
Jang et al[130] | PS | 15 | 100% | 100% | 13% |
Jang et al[131] | RCT | 30 | 97% | 97% | 7% |
Itoi et al[48] | RS | 5 | 100% | 100% | None |
Itoi et al[132] | CR | 1 | 100% | 100% | None |
de la Serna-Higuera et al[133] | RS | 13 | 85% | 85% | 15% |
Widmer et al[134] | RS | 3 | 100% | 100% | None |
Total | 15 studies | 97 | 100% (85%-100%) | 100% (85%-100%) | 0% (0%-37%) |
Complications include: early and late, procedural and stent related. RCT: Randomized controlled trial; PS: Prospective study; RS: Retrospective study; CR: Case report.